(Q37962577)

26 August 2017

title

DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family (English)

1 reference

26 August 2017

0 references

Kwan Yeung Wong

1

1 reference

26 August 2017

Li Yu

series ordinal

2

1 reference

26 August 2017

Chor Sang Chim

series ordinal

3

1 reference

26 August 2017

publication date

1 February 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

3

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

83-92

1 reference

26 August 2017

cites work

Epigenetics in cancer

1 reference

DNA methylation and human disease

21 January 2018

1 reference

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

Worms gang up on bacteria

21 January 2018

1 reference

A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters

21 January 2018

1 reference

Epigenomics: beyond CpG islands.

21 January 2018

1 reference

Large-scale human promoter mapping using CpG islands.

21 January 2018

1 reference

A high-resolution map of active promoters in the human genome

21 January 2018

1 reference

Hypermethylation of gene promoters in hematological neoplasia

21 January 2018

1 reference

21 January 2018

1 reference

DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients

21 January 2018

1 reference

Two genetic hits (more or less) to cancer

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

MicroRNA signatures in human cancers

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

DNA methylomes, histone codes and miRNAs: tying it all together

21 January 2018

1 reference

Mechanisms of microRNA deregulation in human cancer

21 January 2018

1 reference

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

21 January 2018

1 reference

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

21 January 2018

1 reference

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

21 January 2018

1 reference

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

21 January 2018

1 reference

Frequent downregulation of miR-34 family in human ovarian cancers

21 January 2018

1 reference

Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.

21 January 2018

1 reference

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence

21 January 2018

1 reference

MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

21 January 2018

1 reference

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.

21 January 2018

1 reference

MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes

21 January 2018

1 reference

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

21 January 2018

1 reference

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6

21 January 2018

1 reference

MicroRNA-34a regulation of endothelial senescence.

21 January 2018

1 reference

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma

21 January 2018

1 reference

The MYCN oncogene is a direct target of miR-34a

21 January 2018

1 reference

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.

21 January 2018

1 reference

MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells

21 January 2018

1 reference

miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.

21 January 2018

1 reference

MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation

21 January 2018

1 reference

MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response

21 January 2018

1 reference

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

21 January 2018

1 reference

Epigenetic inactivation of the miR-34a in hematological malignancies

21 January 2018

1 reference

TP53 in hematological cancer: low incidence of mutations with significant clinical relevance

21 January 2018

1 reference

Intrinsic tumour suppression

21 January 2018

1 reference

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

Epigenetic regulation of microRNAs in acute lymphoblastic leukemia

21 January 2018

1 reference

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

21 January 2018

1 reference

Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias

21 January 2018

1 reference

Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.

21 January 2018

1 reference

Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia

21 January 2018

1 reference

Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia

21 January 2018

1 reference

CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia.

21 January 2018

1 reference

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

21 January 2018

1 reference

Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor

21 January 2018

1 reference

Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.

21 January 2018

1 reference

Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia

21 January 2018

1 reference

Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes

21 January 2018

1 reference

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

Epigenetic regulation of microRNA expression in colorectal cancer

21 January 2018

1 reference

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

21 January 2018

1 reference

Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer

21 January 2018

1 reference

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

21 January 2018

1 reference

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells

21 January 2018

1 reference

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer

21 January 2018

1 reference

Epigenetic regulation of miR-196b expression in gastric cancer

21 January 2018

1 reference

Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells.

21 January 2018

1 reference

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

21 January 2018

1 reference

Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer

21 January 2018

1 reference

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

21 January 2018

1 reference

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.10.74

1 reference

26 August 2017

1 reference